From pro volleyball to biology: USC scientist is at the top of his game – USC News

For USC Stem Cell researcher Leonardo Morsut, the word set refers to a collection of scientific data. Set is also the prelude to spiking a volleyball over the net something he used to do for a living as a professional athlete in Italy.

Morsut in action on the volleyball court (Photo/Courtesy of Leonardo Morsut)

In my mind, professional volleyball was always a side project, said Morsut, who played for seven years for the professional teams in his hometown of Padova and in Trentino. It was science that was the main thing.

True to his words, Morsut has always put research first. Even while playing pro volleyball for seven hours a day, he found the time and energy to attend the University of Padova, where Galileo was once a lecturer. Morsut earned bachelors and masters degrees in medical biotechnologies before pursuing a second bachelors in mathematics.

Then, at age 25, at the peak of his volleyball career, he quit. He walked away from fame and a handsome salary to lead the humble life of a PhD student at the University of Padova. His decision made national headlines in Italy.

People ask me if I regretted it, he said. I dont even think about leaving that way. There wasnt really a turning point. There was just one path.

As a PhD student, he pursued research in bioscience, genetics and the molecular biology of development. He spent years focused on mouse gastrulation, the early embryonic phase during which a ball of cells organizes itself into distinct layers as a prelude to organ formation.

In the midst of this research, he picked up an unrelated side project: how stem cells behave differently depending upon whether theyre on a hard or a soft surface. Specifically, he and his colleagues found that when stem cells are on a hard surface, they react by producing two signals called YAP and TAZ that encourage them to become bone cells. The side project quickly became his main project, and Morsut and his team published their discovery in the journal Nature.

It was really a rush and a blast, Morsut said. And it was what launched my career because then it was easier to get a postdoc in a bigger lab.

After receiving his PhD and spending an additional postdoctoral year at the University of Padova, he became increasingly fascinated by the emerging field known as synthetic biology.

Synthetic biology is pretty much trying to bring the engineering approach of building things into biology.

Leonardo Morsut

Synthetic biology is pretty much trying to bring the engineering approach of building things into biology, Morsut said. You think about the biological system not as something that you want to learn about, but as something that you want to use to achieve a goal.

Inspired by this approach, he accepted a postdoctoral fellowship in the lab of one of the founders of synthetic biology: Wendell Lim at the University of California, San Francisco.

Wendell and I didnt even know what I was going to work on, but we liked each other, Morsut said.

After some early experimentation, Morsut settled on his main project: building a synthetic cellular communication system known as synNotch, which enables scientists to direct the behavior of cells in useful ways.

Morsut created synNotch by co-opting a relatively simple natural communication system, called Notch, in which a cell uses a sensor on its surface to recognize and trigger a particular response to a specific signal. In Morsuts synthetic version of Notch, he swapped in a new sensor, allowing him to control which signal the sensor recognizes, as well as what the cell does in response.

SynNotch or a similar system could have many potential medical applications. For example, scientists could swap in a sensor that enables an immune cell to recognize a signal from a tumor and then respond with an attack. Alternatively, researchers could use this technology to prompt cells to differentiate and organize into tissues with special properties, such as enhanced injury resistance or regenerative capacity.

The breakthrough earned Morsut a position as the newest assistant professor of stem cell biology and regenerative medicine at USC. At the same time, his wife Sabina accepted a postdoctoral fellowship in art history at the university. Other big changes are on the horizon: The couple, who originally met when they were 12 years old in their hometown of Padova, will expand their family with the arrival of their second child in June.

When hes not enjoying his family or building tissues in the lab, Morsut can be found on the yoga mat, developing his meditation and hatha yoga practice under Yogarupa Rod Stryker.

As he starts his own lab at USC, Morsut plans to use synNotch to direct the differentiation of stem cells into blood vessels, which can supply oxygen and nutrients to engineered tissues and organs in the future. He is also working to develop additional synthetic biology tools and looks forward to collaborating with researchers from across the university, especially at the USC Viterbi School of Engineering and the USC Michelson Center for Convergent Bioscience, slated to open this fall.

The stem cell department is very exciting, and it has a lot of potential and a lot of forward thinking, Morsut said. Engineering is also a strength of USC, and there is interest on both sides to grow more at that interface. That is definitely something that will benefit my research program and vice versa. I have high expectations.

More stories about: Stem Cells

By studying zebrafish, Joanna Smeeton seeks ways to treat a persons aversion to cold and pain.

The gift will support early-stage research projects at three California university stem cell centers, including USCs.

Middle and high school students visit labs and tour USCs stem cell research center,cancer center and Keck Hospital of USC.

Adnan Chowdhury ventures into uncharted scientific territory.

Read more here:
From pro volleyball to biology: USC scientist is at the top of his game - USC News

Unlocking the secrets of the cell to heal humanity – Quad (subscription)

Humanity has come a long way in understanding human biology and the applications of this knowledge to the reduction of human suffering by disease; however, we still have a long way to go. Some of the most basic processes of the cell are still not completely understood, and this lack of understanding leaves humanity in a particularly precarious position.

There are some 20,000 gene-coding proteins in the human cell, and some of the most devastating diseases arise from the dysfunction of just a single gene-product. Niemann-Pick Type C (NPC) represents one of these diseases, and arises when one of two critical NPC genes is mutated in both parents and passed onto their offspring.

When the NPC proteins are mutated, the recycling center of the cell, the lysosome, is unable to recycle certain moleculesmost notably, cholesterol. As a result of this inability to recycle certain molecules, they accumulate inside the cell and ultimately lead to the symptoms associated with NPC disease. Some of the more prominent symptoms associated with this devastating disease include an enlarged liver and spleen, balance problems, seizures, and many other neurological symptoms that usually develop during childhood or early adolescence. The prognosis is very poor, and this disease always results in death.

Though NPC disease is not yet completely understood, there are passionate researchers who have dedicated their careers to understanding how this disease develops and how it might be treated. Understanding NPC disease requires scientists to better understand basic processes of cell metabolism and NPC proteins.

These researchers are committed to unlocking these secrets of the cell and using their findings to develop treatments for NPC. One particularly relevant area of NPC research is focused on understanding why neurons are so disproportionately affected by the disease.

Dr. Steven Walkley, a leading researcher in the field of NPC research, is a Neuroscientist at the Albert Einstein College of Medicine. Walkley has a strong interest in genetic brain diseases and strives to understand not only how NPC disease affects neurons, but is also committed to investigating and developing therapies to treat the disease. Unlike most other cells in the body, the neurons that you are born with do not replicate, and must be maintained for a lifetime.

Walkley stresses that this static nature of brain cells contributes to their keen sensitivity of even the slightest changes in homeostasis. As a result, these cells are disproportionately damaged by the accumulation of cholesterol and other molecules as a result of NPC, and Walkley is determined to understand why this happens and how it can be mitigated.

To better understand how neurons are affected by NPC disease, Walkleys lab studies mice with a naturally occurring NPC disease to understand the disease pathology and potential treatments. In fact, he discovered one of the first treatments for NPC diseasemiglustat, a drug that was originally developed as a potential therapy for Tay-Sachs and Gaucher diseases.

Furthermore, his labs discovery of the amazing therapeutic effects of a compound called cyclodextrin was one of his most significant contributions to the field. Cyclodextrin has been shown to significantly increase the lifespan of mice and cats with naturally occurring models of NPC disease.

Another leading researcher in this field is Dr. Charles Vite, a veterinary Neurologist at the University of Pennsylvania. Vite uses a cat as a model to study NPC disease in the brainstriving to understand why neurons are disproportionately affected and how therapies might mitigate this. He explained that sometimes larger models of the disease better mirror what is seen in the human diseaseand he often works in close collaboration with Walkley to understand how findings in the mouse model compare to the larger cat model. A prominent and vital component of Vites contributions to the field are his investigations on how cyclodextrin treats NPC in his cat model; the results have been extremely uplifting. Upon treatment with cyclodextrin, cats with the disease live about three years longer, on average, than they do when left untreated!

I had the great honor of speaking with both of these leading researchers. During our conversations, I came to realize how truly committed these researchers are to their fields. Their love for neuroscience, deep curiosity and passion to better the lives of individuals afflicted with this disease left me in awe. Thanks to dedicated researchers like Walkley and Vite, scientists are understanding more about NPC and basic cell biology every day. Things are finally starting to look brighter for those who are afflicted with NPC and their families.

Walkley and Vite both agree that cyclodextrin is one of the most promising therapies out there for NPC today, and it is currently in clinical trials. Vite believes that one of the greatest difficulties in working with this disease is that too often, individuals do not receive these developing treatments until the disease has already progressed significantly. To avoid this problem, researchers are looking into the development of newborn screening for NPC, and this is something that will likely be established as a concrete treatment for NPC is developed.

As current students, it is critical to realize the importance of the scientific pursuit of knowledge for humanity. With a better understanding of biology comes an ever- increasing freedom from human disease and suffering. With this in mind, we should dive into our coursework with vigor, and look for opportunities to get involved with current research. Walkley stressed the importance for college students to reach out to local scientists to get involved.

The fight for knowledge is by no means finishedwe will continue this trek into the unknown where scientists of today leave off. With every increase in knowledge, we will bring humanity one step closer to a freedom from human suffering by disease.

Denston Carey is a student majoring in cell and molecular biology. He can be reachedat [emailprotected]

Read the original post:
Unlocking the secrets of the cell to heal humanity - Quad (subscription)

UNCW receives largest ever donation, gift will support … – Port City Daily

PortCityDaily.com is your source for free news and information in the Wilmington area.

WILMINGTON The University of North Carolina Wilmington received a multi-million dollar gift today.

Quality Chemical Laboratories pledged a $5 million gift, to be donated over the next five years. The donation is the largest corporate philanthropic gift in the Universitys history. Quality Chemical Laboratories founder, Dr. Yousry Sayed is a longtime UNCW faculty member in the chemistry department. His wife, Linda Sayed, is a graduate of the University.

UNCW Chancellor Jose Sartarelli said the announcement was some time in the making.

We have been working on this for about a year, Sartarelli said. I have become involved more recently. Aswani Volety, our Dean of the College of Arts and Sciences, was very involved. This was a confluence of good things and good timing.

The Sayeds donation to UNCW will support new programs aimed at advancing study in pharmaceutical and chemistry. According to the administration hopes the gift will help the University further develop recent advances in chemistry, biochemistry, biology and marine biology. Over the coming years, the gift will provide funding for establishing distinguished professorships and research, and may also help support scholarships, faculty research and travel grants.

Sartarelli said the programs will help the school meet the current needs of the state and the growing health care market.

The programs will be under the department of chemistry and biochemistry. Were starting with a Masters program, and we hope to develop a Ph.D. program as well. The goal, of course, is to help connect our students with the growing field of health sciences, with clinical research organizations and testing.

Quality Chemical Laboratories employs many UNCW graduates from the chemisty and biochemistry programs, according to Sartarelli. He hopes the Sayeds gift will help prepare future graduates for similar jobs across the state.

In a press release, Dr. Sayed said he and his wife were happy to be able to give back to their University.

It is an honor to be able to make this small contribution to this great university we love and appreciate, and to invest in the future of this important area of study and the students we serve, said Sayed. My wife and I have been a part of the Seahawk family and have grown together with UNCW for decades, and to know we are contributing to the universitys mission and outcomes in some small way is very rewarding for us.

Read this article:
UNCW receives largest ever donation, gift will support ... - Port City Daily

Anatomy of a Stokes masterclass – ESPNcricinfo.com

Rising Pune Supergiant v Gujarat Lions, IPL 2017, Pune May 1, 2017

Rising Pune Supergiant were 10 for 3 in their chase of 162, and then 42 for 4, but nothing, not even a prolonged bout of cramps, was going to stop Ben Stokes

Star turn

Ever since the last World T20 final, when he was hit for four sixes in the final over of the chase, Ben Stokes has been the subject of some ridicule, especially when sold for a record sum in the IPL auction. Two days before he goes back to his house of horrors, Eden Gardens, Ben Stokes produced one of the great Twenty20 innings. And he did so while hobbling with a cramp in his calf in the last three overs of the chase. Nothing can wipe off what happened in Kolkata last year, but Stokes has done enough in this IPL season to quell those doubts around him.

Coming into this match, Stokes had won two match awards but both for bowling. He had scored only 127 from seven innings before this, but in Pune, coming in to bat in the second over, at the fall of the third wicket. he scored 63% of his team's total. He had batted sooner in an innings only four times before that.

In his 126 a night before, a near-perfect T20 innings, David Warner batted with a 78% control percentage, which is phenomenal when you are attempting to hit a boundary every second ball. Stokes displayed 79% control. That control percentage was bound to be higher because he hit only one boundary every five balls as against Warner's one every three balls, but the fact Stokes couldn't afford to keep swinging made this innings special.

Stokes also struggled against legspinner Ankit Soni. He picked the wrong 'uns out of the back of the hand, but the sliders out of the front of the hand kept going past his outside edge. The 11 balls Soni bowled to Stokes, for seven runs, brought his control percentage down. So Stokes had to strike against others but in a calculated manner because four wickets fell within the first six overs, and because MS Dhoni faced 10 dots in his first 12 balls.

So Stokes struck against Ravindra Jadeja to break the shackles, and then kept finding the boundary every time the asking rate threatened to go out of hand.

The wow moment

Things can happen before you realise in T20 cricket. You are four down early, you are looking to arrest the slide, and two spinners can run through six overs in no time. When you look up at the board, you can be staring at an unachievable asking rate. The previous 19 balls had got Rising Pune just nine runs, with the asking rate shooting from 8.5 to 10. Then Stokes swung. Bang and bang, Ravindra Jadeja was hit over midwicket and long-on. The innings was back on track, and this was the last over Jadeja bowled because Gujarat Lions couldn't get rid of Stokes at all.

ESPNcricinfo Ltd

Stats that matter

What they said

"Stokesy is a quality player and he certainly earned his cash." Enough said, captain Steven Smith

"We lost quite a few early wickets... Me and MS [Dhoni] just tried to keep it ticking. We just tried to go big at the start of the over, and cool it off." Ben Stokes on how he approached the chase

Sidharth Monga is an assistant editor at ESPNcricinfo

ESPN Sports Media Ltd.

Continue reading here:
Anatomy of a Stokes masterclass - ESPNcricinfo.com

‘Grey’s Anatomy’ Season 13 Finale Synopsis Revealed – Wetpaint – Wetpaint

Credit: Richard Cartwright/ABC 2017 Disney | ABC Television Group. All rights reserved.

With only three installments left in Greys Anatomy Season 13, were already getting jittery thinking of all the drama the season finale will unleash.

And a new synopsis from ABC only ups the anxiety!

Per Screener, heres ABCs first synopsis for the May 18 season-capper:

A dangerous patient escapes the hospital room, putting the doctors lives at risk; Alex faces a difficult decision in his relationship with Jo; Meredith has big news for Nathan.

Lets break down that tease clause by clause. First up: A dangerous patient escapes the hospital room, putting the doctors lives at risk.

If a fire does indeed break out at Grey Sloan Memorial, we imagine its this patient who starts it. Perhaps dangerous is code for pyromaniac here.

(The synopsis for the preceding episode also mentions a dangerous patient, whom we imagine is the same person.)

Next, Alex faces a difficult decision in his relationship with Jo.

One week earlier, hell attend a medical conference after making a shocking discovery, that episodes synopsis reveals.

Were guessing that shocking discovery will be the identity of Jos abusive husband, maybe the character Glee star Matthew Morrison is playing, as fans are conjecturing. (Matthews character is another guest at that conference, after all.)

So perhaps Alex will be dealing with the fallout of his encounter with Jos ex when the finale rolls around.

Then again, Shonda Rhimes always subverts our expectations, and wed bet good money she wants us to think big news will mean big baby bump just so well be caught off-guard by a season finale curveball.

But how does she expect us to sleep between now and May 18?!

Greys Anatomy Season 13 airs on Thursdays at 8 p.m ET on ABC.

Read more:
'Grey's Anatomy' Season 13 Finale Synopsis Revealed - Wetpaint - Wetpaint

Scoop: GREY’S ANATOMY on ABC – Thursday, May 18, 2017 – Broadway World

On the episode Ring of Fire, the doctors lives are at risk after a dangerous patient escapes the hospital room. Alex must make a hard choice in his relationship with Jo while Meredith has some big news for Nathan that brings things to a turning point, on the season finale of Greys Anatomy, THURSDAY, MAY 18 (8:00-9:01 p.m. EDT), on The ABC Television Network.

Greys Anatomy stars Ellen Pompeo as Meredith Grey, Justin Chambers as Alex Karev, Chandra Wilson as Miranda Bailey, James Pickens Jr. as Richard Webber, Kevin McKidd as Owen Hunt, Jessica Capshaw as Arizona Robbins, Jesse Williams as Jackson Avery, Sarah Drew as April Kepner, Caterina Scorsone as Amelia Shepherd, Camilla Luddington as Jo Wilson, Jerrika Hinton as Stephanie Edwards, Kelly McCreary as Maggie Pierce, Jason George as Ben Warren, Martin Henderson as Nathan Riggs and Giacomo Gianniotti as Andrew DeLuca.

Greys Anatomy was created and is executive produced by Shonda Rhimes (Scandal, How to Get Away with Murder), Betsy Beers (Scandal, How to Get Away with Murder) and Mark Gordon (Saving Private Ryan). William Harper, Stacy McKee, Zoanne Clack and Debbie Allen are executive producers. Greys Anatomy is produced by ABC Studios.

Guest Starring are Debbie Allen as Catherine Avery and Marika Dominczyk as Eliza Minnick.

Ring of Fire was written by Stacy McKee and directed by Debbie Allen.

Greys Anatomy is broadcasted in 720 Progressive (720P), ABCs selected HTV format, with 5.1-channel surround sound.

Read the original post:
Scoop: GREY'S ANATOMY on ABC - Thursday, May 18, 2017 - Broadway World

Mother Makes Ultimate Sacrifice for Unborn Child on ABC’s Grey’s Anatomy – LifeNews.com

In a society where preborn children are treated as disposable property, and disregarded in the name of cold, sterile, euphemisms such as reproductive rights and choice, its rare to find a mother who actually does the opposite of putting herself above her child.

But in April 27ths episode of Greys Anatomy on ABC, we got to see that rarity played out in a heart-wrenching yet inspiring storyline.

Patient Veronica is in the ER at Grey-Sloan Memorial Hospital for back pain. Shes almost 35 weeks pregnant and her body is riddled with cancer. She decided to forgo cancer treatment because, as she put it, I didnt want to microwave the baby.

The storyline is a continuation from earlier this season when Veronica refused to abort her baby despite pressure from Doctor Miranda Bailey (Chandra Wilson) to kill her child to begin treatments for her terminal pancreatic cancer. (See previous article for factual information on cancer during pregnancy as well, as this episode did not accurately reflect the truth on the effects of chemotherapy and radiation on a preborn baby.)

The prognosis isnt good, as was expected, and as Veronica planned for. The doctors give her two months at best left to live, as the cancer has spread even further and is compressing her spinal cord. And they tell her that they must deliver the baby that day.

Follow LifeNews.com on Instagram for pro-life pictures.

All right. Lets cheer up, everybody. Were having a baby, Veronica announces optimistically, looking forward to having two months to spend with her baby and the babys father.

But during the C-section, things take a turn for the worst:

Amelia: Heart rates up to 130. Veronica, hows yourbreathing?

Veronica: Its fi um, its a little tough.

Jeremy: Whats happening? Whats going on?

Veronica: Hey, Jer, come on. Look at him.He has the sweetest eyes.

Arizona: Her sats are dropping. Shes persistentlytachycardic.

Amelia: Lets put her back on high-flow oxygen.It could be an embolus.

Veronica: Time to get him out of here.

Alex: Yeah, in a minute.

Arizona: If its an embolus, we dont have a minute.

Alex: She did all this so she can meet the baby.Just give them another damn minute.

Veronica: Jer, can you take him?

Alex: He needs to go to the NICU now.

Jeremy: And, uh, what what about Veronica?

Alex: Shes in good hands. Shell be just fine.Ill take good care of her.

Veronica: Jer, you stay with him.You promised. Im counting on you.

Jeremy: But I dont

Veronica: Go on. Stay with him.Ill see you in a little bit.

Amelia: Are we pushing heparin or going straightto thrombolytics?

Arizona: Thrombolytics are contraindicated.We need to do an embolectomy, and lets getan ivc filter.

Amelia: Veronica, youve thrown a blood clot,and its traveled all the way to your lungs.Its very serious. We need to remove it immediately,so were gonna need to put you under andopen up your chest.

Veronica: Is thatUhUh, will that work?

Amelia: The procedure will only last about a halfan hour.

Veronica: Will it work?

Amelia: Theres no guarantee youd survive it.

Veronica: And what if we didnt do anything?

Arizona: Veronica, we need to do this procedure.If we dont, you might not make it off thistable today.

Amelia: Okay, pressures dropping. Get a cart ready!

Veronica: No. I signed that dnr for a reason.

Arizona: You can rescind. Let us help you.

Veronica: I did what I wanted. My babysokay.It Im so tired.

Amelia: I know.I know.

Too bad Dr. Miranda Bailey wasnt around to see that beautiful baby alive and well thanks to his mother not listening to her pro-abortive advice.

Later, we see Veronica in her last moments and realize even further what an amazing mother she was to give up her own life for her childs:

Amelia: What do you want? What do you needright now?

Veronica: Im so cold.

Amelia: Ill get a warming blanket.

Veronica: No! No.Can you Will you just hold me?We did good?The babys good?

Amelia: Babys good.

Yes, Veronica, you did good. And your baby is so very good because of your beautiful sacrifice.

LifeNews Note: Dawn Slusher writes for Newsbusters, where this originally appeared.

Originally posted here:
Mother Makes Ultimate Sacrifice for Unborn Child on ABC's Grey's Anatomy - LifeNews.com

Anatomy of a Goal: Jack Harrison’s Game Winner – Massive Report

Welcome to Anatomy of a Goal, where each week we dissect one goal from the previous weeks Columbus Crew SC match.

For Week 9 of the 2017 MLS season, we take a look at Jack Harrisons 76th minute goal that gave New York City FC a 3-2 lead as part of their win over Crew SC on Saturday.

Heres a look at the finish from the NYCFC winger.

Crew SC were on the back foot for much of second half of Saturdays match. Columbus manger Gregg Berhalter admitted as much after the match, suggesting that the Black & Gold lost complete control of the match after taking a second half lead.

Berhalter said #CrewSC lost complete control of the match after taking the lead early in the second half.

NYCFCs game winner began with an Alexander Callens long-ball to winger Rodney Wallace. In the above image, note the Crew SC pressure forcing the NYCFC center back to play a 50/50 ball into the Columbus defensive half. Black & Gold midfielder Mohammed Abu likely should have been covering someone in the middle of the field, but he does begin to track back to his defensive half as he sees Callens make the deep pass.

Wallace receives the ball in a difficult position, and attempts to flick the ball into the path of City striker Sean Okoli. Jonathan Mensah is well positioned to defend this pass, and easily beats Okoli to the ball.

On the far right side of the above image, just to the right of the referee, you can just see Yangel Herrera, who will have the assist on Harrisons goal. Abu is just behind Herrera.

As Jonathan approaches the ball he has three options: a drop pass to goalkeeper Zack Steffen who has a full view of the field, a square pass to right back Harrison Afful or kick the ball way over the head of Afful and out of bounds letting Crew SC regroup defensively. A pass to Steffen is probably the worst option, but any of these three choices should have given his side a chance to move the ball back up the field.

Jonathan opts to make the easy pass to Afful, who will immediately be pressed by Wallace. Both Wallace and Okoli were prepared to pressure the Crew SC back line as soon as the ball was turned over, and that press will force Afful to make a quick decision.

As Afful prepares to receive the ball, he has four immediate options: a drop pass to Steffen, a pass back up the field to Wil Trapp (just to the right of this image), a pass to center-back Nikolai Naess, splitting Okoli and Wallace or a pass back to Jonathan if he moves into a better position.

A pass to Trapp, who was unmarked, would have been ideal but was likely just out of Affuls view and made for a difficult option under the pressure of Wallace.

Before we move on, pay attention to the huge space between the back line and the Crew SC midfielders. From this view, you cant even see Abu or Trapp, though Trapp gets to the sideline in time to theoretically receive a pass. Though Abu began tracking back, he isnt able to make himself useful in this play, showing the value injured Artur with his ability to cover acres of space.

Wallace closes down Affuls angle to the sideline and Okoli pressures Jonathan, removing two of the right backs passing options. Jonathan takes his run in the path of Steffen, effectively bringing Okoli into the path of Steffen as well, further limiting Affuls passing options.

With only one real option to choose from, Afful elects to make a seemingly difficult pass to Naess in the middle of the field. Afful likely sees Naess, highlighted on the right side of the image, and is likely unable to see Herrera sprinting downfield (Editors note, this was confirmed by Afful postgame). From Naesss reaction to Affuls pass, he also did not notice the NYCFC midfielder heading his way.

From this angle, Affuls pass to Naess looks slightly less difficult than the previous view. Wallace may just be cutting off Affuls vision of the right side of the field, hiding the sprinting Herrera from view.

Now is when things really start to go downhill for the Black & Gold. Somehow, Naess did not noticed Herrera blazing toward the ball. Judging by Naesss nonchalant jog toward the ball, it doesnt seem like anyone tells him that Herrera is bearing down on him. Abu still hasnt been able to get in front of Herrera, and will soon slow to a jog and fully give up on this play.

Had Naess not switched off, he would have had a very easy one-touch pass to a totally unmarked Trapp.

Herrera is able to get to the ball at the same time as the Crew SC center back. As you will see below, Herrera is able to deflect the ball around Naess to set up his assist to Harrison. Abu has totally slowed up, and spends the rest of the play doing little more than halfheartedly jogging toward the goal.

In the video above, you can see just how blindsided Naess was by Herrera. I wasnt able to hear what was happening on the field, but if the team is communicating as it should have been (i.e. Steffen and Abu both yelling to Naess about the impending collision with Herrera), then this goal should not have happened.

Once Herrera has deflected the ball around Naess, he sets off a footrace to the ball with the Crew SC defender. Finally, Harrison has arrived on the scene running totally unmarked into the Crew SC goal box. Harrison was able to catch Columbus left back Jukka Raitala too far up the field, and easily beats him back into the attack.

As Herrera beats Naess to the ball, he has a very simple pass to Harrison, who remains unmarked. Raitala has closed down the distance to Harrison, but will be unable to catch the NYCFC winger.

Naess is able to make Herreras pass more difficult than initially anticipated, forcing the City midfielder to make a sliding pass into the path of his teammate. Raitala continues to close down Harrison, but the speedy winger will just beat Raitala and Naess to the ball.

To Raitalas credit, he nearly catches Harrison before he can slot the ball between Steffens legs. Still, neither Raitala nor Naess are able to get in front of Harrisons shot.

Notice Steffens positioning. He has made himself wide in front of Harrison, but his legs are spread very far apart, giving Harrison an easy path to goal.

Note the above video to see just how open Harrison was. Even though Harrison had to slow down his run he still gets to the ball before anyone from Crew SC.

Not the best look for Steffen in the image above. The Crew SC goalkeeper, who had already been chipped for Harrisons first goal, gets nutmegged for the game winner.

Findings:

Excerpt from:
Anatomy of a Goal: Jack Harrison's Game Winner - Massive Report

Eric Dane, most famous for playing Dr. Mark ‘McSteamy’ Sloan on Grey’s Anatomy, is suffering from depression and has … – 9Honey

Eric Dane, most famous for playing Dr. Mark 'McSteamy' Sloan on Grey's Anatomy, is suffering from depression and has halted production on his current show, The Last Ship.

"Eric asked for a break to deal with personal issues," his rep told Us Weekly. "He suffers from depression and has asked for a few weeks of downtime, and the producers kindly granted that request. He looks forward to returning."

According to Variety, the Michael Bay-produced series will go on hiatus through the end of May. The action-drama, in which Eric plays a ship captain trying to save the world from a deadly virus, is set to debut its fourth season this winter.

Eric, 44, starred as McSteamy on Grey's Anatomy for six years before leaving the show in 2012. He has also had roles in Marley & Me and Valentine's Day.

The dad to daughters Billie, 7, and Georgia, 5, (with his actress wife Rebecca Gayheart) previously entered rehab in 2011 to deal with a painkiller addiction following a sports injury.

"I honestly think I'm exactly where I'm supposed to be at this moment in time," the actor told People in 2014. "And I'm really happyWe've all made mistakes. My one regret is that I got the person I love most wrapped up in all that: Rebecca."

Eric was referring to a 2009 leaked nude tape featuring himself, Rebecca, and a third woman named Kari Ann Peniche.

"From what I've seen it's a naked tape, not a sex tape," Eric's lawyer said at the time. "At most, it's three people maybe wanting to have sex."

Related Video: Grey's Anatomy's Jesse Williams gives powerful BET Awards speech

TV and movie cast reunions: Nostalgic photos to give you all the feels

View original post here:
Eric Dane, most famous for playing Dr. Mark 'McSteamy' Sloan on Grey's Anatomy, is suffering from depression and has ... - 9Honey

Lab test could change immunology – Post-Bulletin

Imagine using a hand-drawn sketch to identify a person in a crowd.

Now imagine switching to a high-resolution photo to make a match.

That's the shift some researchers at Mayo Clinic and the England-based The Binding Site firm are hoping to make in diagnosing and tracking the progression of multiple myeloma cancer in patients.

"It's night and day difference in terms of the resolution," Dr. David Murray said of using a mass spectrometer versus the decades-old process of gel electrophoresis.

Murray and David Barnidge, Ph.D, have invented a new testing process that uses the mass spectrometer to look for the build up of monoclonal immunoglobulin or "M-Proteins," which can signal the development of the currently incurable cancer in a patient.

They created it in Mayo Clinic's labs in the Hilton Building. Mayo Clinic patented the process, and now it's working with its longtime collaborator The Binding Site to fine-tune the test and eventually work toward having it approved by the U.S. Food and Drug Administration. Mayo Clinic has financial investment in the project. The collaboration uses patents owned by Mayo Clinic and The Binding Site, plus several patents jointly held by both organizations.

The collaboration has spurred The Binding Site to establish a research laboratory in northwest Rochester to focus on the project. In May, a 5,200-square-foot lab was built out in the first level of the Wideth Smith Nolting Building, formerly the Home Design Center, along West Circle Drive.

"It all just came together," said Barnidge, standing in blindingly white new laboratory space. Barnidge, who now works for The Binding Site as laboratory director, is outfitting the lab with the necessary equipment and hiring seven researchers to staff it.

Brian DuChateau, the vice president of development for The Binding Site, explains the progression of the collaboration as going through three phases.

"First, it was negotiating terms with Mayo. The next phase is to locate, build and establish the Rochester lab," DuChateau said. "The third phase is development and validation of the test. That's the fun part we're looking forward to getting to."

However, he cautions it probably will take years before the test is considered by the FDA for approval.

Meanwhile, Mayo Clinic is working on a parallel to gain approval to use the test just for its patients. Murray said that separate process could wrap up by the end of 2017.

"We're leading the charge. We want to eventually get this thing out in the hands of the other institutions," Murray said.

This approach stems from when a medical resident with an unusual background arrived at Mayo Clinic's Protein Immunology Lab and saw they were using the gel electrophoresis that dates back to the late 1950s.

Long before becoming a physician, Murray earned a doctorate in chemistry, and he worked as a research chemist for Eastman in Tennessee. After 10 years in that job, he "got the crazy idea to go to medical school." That led him to see how the immunology lab was doing its testing.

"As an industrial chemist, it was like, I knew there were much better ways to do this," he said.

He soon joined forces with Barnidge, as well as Mayo Clinic's Dr. John Mills and others. They soon started doing things with a mass spectrometer that had never been done before. By 2014, they had worked out a new test.

Overall, Barnidge and Murray say their patented test is more efficient, faster and less expensive than the ones in use now. Plus, there is detail that is just not possible with the gels.

"We're seeing details that we've never see before about the antibody repertoire. There are things that I think eventually will change how we think about immunology," said Murray.

DuChateau said this process could open the door for many new tests.

"It's the ultimate diagnostic. If you can ionize it, in theory, you can use this for a lot of different things. Ultimately, this is not just one single project for our Rochester lab," he said.

Go here to read the rest:
Lab test could change immunology - Post-Bulletin